Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing

Clinical Chemistry

Volumn 52, Issue 4, 2006, Pages 743-746

  Woodworth, Alison ^a   Saunders, Al N ^b   Koenig, John W ^b   Moyer, Thomas P ^c   Turk, John ^a   Dietzen, Dennis J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CHLORPHENIRAMINE; EPHEDRINE; METHAMPHETAMINE; PHENTERMINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE;

ARTICLE; CLINICAL ARTICLE; CROSS REACTION; DOSE RESPONSE; DRUG ABUSE; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; LABORATORY TEST; MASS SPECTROMETRY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; THIN LAYER CHROMATOGRAPHY;

AMPHETAMINE; CROSS REACTIONS; EPHEDRINE; HUMANS; IMMUNOASSAY; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; ROC CURVE; SUBSTANCE ABUSE DETECTION; SYMPATHOMIMETICS;

EID: 33645460733     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.060616     Document Type: Article

References (9)

1. Substance Abuse and Mental Health Services Administration, Results from the 2002 National Survey on Drug Use and Health: National Findings. SMA 03-3836, NHSDA Series H-22. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2003.
2. Dietzen DJ, Ecos K, Friedman D, Beason S, Positive predictive values of abused drug immunoassays on the Beckman Synchron in a veteran population. J Anal Toxicol 2001;25:174-8.
3. Ferrara SD, Tedeschi L, Frison G, Brusini G, Castagna F, Bernardelli B, et al. Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and Chromatographic techniques. J Anal Toxicol 1994;18:278-91.
4. Grinstead GF, Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine/methamphetamine assay. Clin Chem 1989;35:1998-9.
5. Poklis A, Hall KV, Still J, Binder SR. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay. J Anal Toxicol 1991;15:101-3.
6. Dasgupta A, Saldana S, Kinnaman G, Smith M, Johansen K. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Clin Chem 1993;39:104-8.
7. D'Nicuola J, Jones R, Levine B, Smith ML. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. J Anal Toxicol 1992;16:211-3.
8. Luzzi VI, Saunders AN, Koenig JW, Turk J, Lo SF, Garg UC, et al. Analytic performance of immunoassays for drugs of abuse below established cutoff values. Clin Chem 2004;50:717-22.
9. Polettini A, Groppi A, Vignali C, Montagna M. Fully-automated systematic lexicological analysis of drugs, poisons, and metabolites in whole blood, urine, and plasma by gas chromatography-full scan mass spectrometry. J Chromatogr B Biomed Sci Appl 1998;713:265-79.